U.S. Court of Appeals for the Federal Circuit
Glaxosmithkline LLC v. Teva Pharmaceuticals USA, Inc.
This writing
- Type
- Opinion
- Author
- Kimberly Ann Moore
- Filed
- Feb. 11, 2022
- Case
- Glaxosmithkline LLC v. Teva Pharmaceuticals USA, Inc.
- Case status
- Decided
Source The authoring judge was read from the signature line of the court's own published opinion, not from provider metadata — CourtListener records no author for most Sixth Circuit opinions.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 18-1976 Document: 244 Page: 1 Filed: 02/11/2022 United States Court of Appeals for the Federal Circuit ______________________ GLAXOSMITHKLINE LLC, SMITHKLINE BEECHAM (CORK) LIMITED, Plaintiffs-Appellants v. TEVA PHARMACEUTICALS USA, INC., Defendant-Cross-Appellant ______________________ 2018-1976, 2018-2023…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.